We deliver innovative biotech PR solutions
We work with the biotech “little dogs.”
Little dogs are innovative biotech companies, both big and small, that are developing tomorrow’s medicines and technologies to improve healthcare. We provide strategic biotech public relations (PR) and corporate communications, including press releases, media outreach, websites, and investor presentations.
Our clients are developing new therapeutics for rare diseases, advancing stem cell therapies in the clinic, advancing personalized diagnostics for cancer, unlocking the power of genomics and synthetic biology, 3D bioprinting new solutions for drug discovery and human disease research, and creating medical devices with the power to cure chronic and fatal diseases.
“Little Dog has the right mix of intelligence, creativity, and determination to build a compelling branding and communication strategy.”
– Paulo Rangel, President and CEO of Primmune Therapeutics
“Little Dog knows the science, is smart on the strategy and works diligently to achieve our communications goals.”
– Jay Lichter, Ph.D., Partner, Avalon Ventures and President and CEO, COI Pharmaceuticals
We speak science. It’s in our DNA.
With our biomedical research backgrounds and biotech communications experience, we translate the science and technology into the value story that matters for your stakeholders and business goals.
The DNA of communications is both science and art.
“It’s more than a website, a PowerPoint or a press release, it’s your story. It needs to inspire others, so together you can achieve something important.”
– Jessica Yingling, Ph.D.,
president of Little Dog Communications
Our public relations firm is located in San Diego, California and Salt Lake City, Utah with biotech and life science clients worldwide.
Learn more about what we can do for you